SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Biotech Beach
The Day In Review: Amgen Drags Biotech Lower
January 26, 2007
 · 
1 min read
Drug Development
Avastin Fails Trials For Pancreatic Cancer
January 24, 2007
 · 
1 min read
Biotech Beach
The Day In Review: Bristol-Myers Squibb Company In $1.2 Billion Pact With AstraZeneca PLC
January 11, 2007
 · 
1 min read
Biotech Beach
The Day In Review: Genentech, Inc. Handily Beats Estimates
January 10, 2007
 · 
1 min read
Biotech Beach
The Day In Review: Genentech, Inc. Adds To Pipeline, Again
January 9, 2007
 · 
1 min read
BioForest
The Day In Review: Seattle Genetics, Inc. Sells Cancer Drug To Genentech, Inc.
January 8, 2007
 · 
1 min read
Biotech Beach
The Day In Review: Two Big Deals To Start The New Year
January 3, 2007
 · 
1 min read
Biotech Beach
The Day In Review: Deals Dominate Biotech News
December 12, 2006
 · 
1 min read
Biotech Bay
The Day In Review: Another Indication For Herceptin From Genentech, Inc.
November 17, 2006
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Business
Genentech Announces First Milestone Payment to Device-Maker ForSight Labs, LLC VISION4, Inc. in Development of Sustained Delivery Lucentis
January 17, 2012
 · 
1 min read
Business
Genentech Pours $95 Million into Constellation Pharmaceuticals Epigenetic Drug Platform, Deal Includes M&A Terms
January 17, 2012
 · 
4 min read
Biotech Bay
Genentech Announces First Milestone Payment to Device-Maker ForSight Labs, LLC VISION4, Inc. in Development of Sustained Delivery Lucentis
January 13, 2012
 · 
1 min read
Business
Vernalis PLC Signs Drug-Discovery Deal With Genentech
January 4, 2012
 · 
1 min read
Policy
Regeneron Pharmaceuticals, Inc. Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA(TM) (aflibercept) Injection
January 3, 2012
 · 
3 min read
Drug Development
Genentech Initiates First-in-Human Study with NovImmune SA’s Anti-IL17 Antibody
December 13, 2011
 · 
1 min read
Business
Dako A/S Enters Into Collaboration With Genentech on the Regulatory Submissions of Dako’s HercepTest(TM) and HER2 FISH pharmDx(TM) as Companion Diagnostics for Pertuzumab
December 9, 2011
 · 
1 min read
Drug Development
Genentech’s Two-Drug Strategy Raises the Bar in Breast Cancer, Positive Phase III Results Reported
December 8, 2011
 · 
10 min read
Drug Development
Genentech to Present Important New Data for HER2-Positive Breast Cancer at 2011 San Antonio Breast Cancer Symposium
November 30, 2011
 · 
9 min read
BioCapital
Genentech’s Avastin Ousted by FDA for Breast Cancer, Sunshine Biopharma, Inc. Gears-Up for Clinicals
November 29, 2011
 · 
3 min read
Load More